Synthetic Red Blood Cell-Specific Glycolytic Intermediate 2,3-Diphosphoglycerate (2,3-DPG) Inhibits Plasmodium falciparum Development In Vitro.
Front Cell Infect Microbiol
; 12: 840968, 2022.
Article
in En
| MEDLINE
| ID: mdl-35372095
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Plasmodium falciparum
/
Malaria
Limits:
Animals
Language:
En
Journal:
Front Cell Infect Microbiol
Year:
2022
Document type:
Article
Affiliation country:
Portugal
Country of publication:
Switzerland